BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye L, Xu Y, Wang L, Zhang C, Hu P, Tong S, Liu Z, Tian D. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. Cancer Med 2021;10:8100-13. [PMID: 34612013 DOI: 10.1002/cam4.4320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Chen S, Wang Z, Li J, Yuan Y, Feng W, Li W, Chen M, Liu Y. Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1061597] [Reference Citation Analysis]
2 Pan B, Xia Y, Fang S, Ai J, Wang K, Zhang J, Du C, Chen Y, Liu L, Yan S. Integrated network pharmacology and serum metabolomics approach deciphers the anti-colon cancer mechanisms of Huangqi Guizhi Wuwu Decoction. Front Pharmacol 2022;13:1043252. [DOI: 10.3389/fphar.2022.1043252] [Reference Citation Analysis]
3 Meng D, Liu T. A lipid metabolism-related risk signature for patients with gliomas constructed with TCGA and CGGA data. Medicine (Baltimore) 2022;101:e30501. [PMID: 36086728 DOI: 10.1097/MD.0000000000030501] [Reference Citation Analysis]
4 Jia W, Zhu H, Zhao M, Zhou Q, Yin W, Liu W, Wang L, Xiao Z, Jiang X, Dai J, Ren C. Potential mechanisms underlying the promoting effects of 3D collagen scaffold culture on stemness and drug resistance of glioma cells. Biochim Biophys Acta Mol Basis Dis 2022;1868:166522. [PMID: 35981653 DOI: 10.1016/j.bbadis.2022.166522] [Reference Citation Analysis]
5 Zhang C, Liu H, Tan Y, Xu Y, Li Y, Tong S, Qiu S, Chen Q, Su Z, Tian D, Zhou W, Zhong C. MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients. Front Immunol 2022;13:865020. [DOI: 10.3389/fimmu.2022.865020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 de Souza I, Ramalho MCC, Guedes CB, Osawa IYA, Monteiro LKS, Gomes LR, Rocha CRR. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment. IJMS 2022;23:6879. [DOI: 10.3390/ijms23136879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wei J, Zhang C, Ma L, Zhang C. Artificial Intelligence Algorithm-Based Intraoperative Magnetic Resonance Navigation for Glioma Resection. Contrast Media Mol Imaging 2022;2022:4147970. [PMID: 35317129 DOI: 10.1155/2022/4147970] [Reference Citation Analysis]
8 Ye L, Xu Y, Wang L, Zhang C, Hu P, Tong S, Liu Z, Tian D. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. Cancer Med 2021;10:8100-13. [PMID: 34612013 DOI: 10.1002/cam4.4320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]